Matthew Diamond, MD, PhD is the Chief Medical Officer at FDA’s Digital Health Center of Excellence. Serving as the senior clinical expert for digital health medical devices at the Center for Devices and Radiological Health (CDRH), Dr. Diamond provides clinical leadership for policy development on digital health technologies including artificial intelligence-enabled medical devices. Dr. Diamond represents FDA for national and international digital health initiatives including as Chair of the International Medical Device Regulators Forum (IMDRF) Artificial Intelligence Working Group. Prior to joining the Agency, Dr. Diamond served on leadership teams of large and small technology companies, including as Chief Medical Officer at Nokia, and on numerous advisory boards including for the Center for Personalized Health Monitoring at UMass Amherst and the venture firm NGP Capital. As Vice Chair of the Consumer Technology Association (CTA) Health & Fitness Technology Board of Directors, he promoted public health applications of mobile technology and established an ANSI-accredited standardization committee to develop standards in digital health for wellness-related products. Dr. Diamond earned his MD and PhD (biophysics) from the Mount Sinai School of Medicine, and he is board certified in rehabilitation medicine and certified in medical acupuncture. A faculty member at NYU, Dr. Diamond is passionate about helping people improve their mobility and performance through a holistic approach to rehabilitation and technology that promotes wellness.